{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:51:38Z","timestamp":1762113098421},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,4,24]],"date-time":"2008-04-24T00:00:00Z","timestamp":1208995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"},{"start":{"date-parts":[[2008,4,24]],"date-time":"2008-04-24T00:00:00Z","timestamp":1208995200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hematopathol"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1007\/s12308-008-0003-y","type":"journal-article","created":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T09:21:13Z","timestamp":1208942473000},"page":"11-21","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Analysis of single nucleotide polymorphisms in the FAS and CTLA-4 genes of peripheral T-cell lymphomas"],"prefix":"10.1007","volume":"1","author":[{"given":"Irina","family":"Bonzheim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Geissinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Yu","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Str\u00f6bel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Marx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Reimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Puppe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Konrad","family":"M\u00fcller-Hermelink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"R\u00fcdiger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,24]]},"reference":[{"key":"3_CR1","volume-title":"Mature T-cell and NK-cell neoplasms. In: Tumours of Haematopoietic andLymphoid Tissues","author":"ES Jaffe","year":"(2001)","unstructured":"Jaffe ES, Harris NL, Stein H et al (2001) Mature T-cell and NK-cell neoplasms. In: Tumours of Haematopoietic andLymphoid Tissues. IARC, Lyon"},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/path.2046","volume":"210","author":"E Geissinger","year":"(2006)","unstructured":"Geissinger E, Bonzheim I, Krenacs L et al (2006) Nodal peripheral T-cell lymphomas correspond to distinct mature T-cell populations. J Pathol 210:172\u2013180","journal-title":"J Pathol"},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1182\/blood-2005-03-1083","volume":"106","author":"KL Grogg","year":"(2005)","unstructured":"Grogg KL, Attygalle AD, Macon WR et al (2005) Angioimmunoblastic T-cell lymphoma: a neoplasm of germinal-center T-helper cells? Blood 106:1501\u20131502","journal-title":"Blood"},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/00000478-200604000-00009","volume":"30","author":"J Dupuis","year":"(2006)","unstructured":"Dupuis J, Boye K, Martin N et al (2006) Expression of CXCL13 by neoplastic cells in angioimmunoblastic T-cell lymphoma (AITL): a new diagnostic marker providing evidence that AITL derives from follicular helper T cells. Am J Surg Pathol 30:490\u2013494","journal-title":"Am J Surg Pathol"},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nri1714","volume":"5","author":"CG Vinuesa","year":"(2005)","unstructured":"Vinuesa CG, Tangye SG, Moser B et al (2005) Follicular B helper T cells in antibody responses and autoimmunity. Nat Rev Immunol 5:853\u2013865","journal-title":"Nat Rev Immunol"},{"key":"3_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1146\/annurev.immunol.22.012703.104702","volume":"22","author":"F Sallusto","year":"(2004)","unstructured":"Sallusto F, Geginat JLanzavecchia A (2004) Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol 22:745\u2013763","journal-title":"Annu Rev Immunol"},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1034\/j.1600-065X.2003.00051.x","volume":"193","author":"DR Green","year":"(2003)","unstructured":"Green DR, Droin NPinkoski M (2003) Activation-induced cell death in T cells. Immunol Rev 193:70\u201381","journal-title":"Immunol Rev"},{"key":"3_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/00062752-199603010-00006","volume":"3","author":"CM Rudin","year":"(1996)","unstructured":"Rudin CM, Van Dongen JThompson CB (1996) Apoptotic signaling in lymphocytes. Curr Opin Hematol 3:35\u201340","journal-title":"Curr Opin Hematol"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1182\/blood.V99.2.627","volume":"99","author":"A Attygalle","year":"(2002)","unstructured":"Attygalle A, Al-Jehani R, Diss TC et al (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. Blood 99:627\u2013633","journal-title":"Blood"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1182\/blood.V94.9.3067","volume":"94","author":"G Cutrona","year":"(1999)","unstructured":"Cutrona G, Leanza N, Ulivi M et al (1999) Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo. Blood 94:3067\u20133076","journal-title":"Blood"},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"2528","DOI":"10.1182\/blood.V97.8.2528","volume":"97","author":"M Cutrona GFerrarini","year":"(2001)","unstructured":"Cutrona GFerrarini M (2001) Expression of CD10 by human T cells that undergo apoptosis both in vitro and in vivo. Blood 97:2528","journal-title":"Blood"},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1038\/sj.bjc.6600329","volume":"86","author":"G Cutrona","year":"(2002)","unstructured":"Cutrona G, Tasso P, Dono M et al (2002) CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL. Br J Cancer 86:1776\u20131785","journal-title":"Br J Cancer"},{"key":"3_CR13","first-page":"864","volume":"11","author":"R Lai","year":"(1998)","unstructured":"Lai R, Arber DA, Chang KL et al (1998) Frequency of bcl-2 expression in non-Hodgkin\u2019s lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. Mod Pathol 11:864\u2013869","journal-title":"Mod Pathol"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1006\/clim.1999.4767","volume":"93","author":"Y Choi","year":"(1999)","unstructured":"Choi Y, Ramnath VR, Eaton AS et al (1999) Expression in transgenic mice of dominant interfering Fas mutations: a model for human autoimmune lymphoproliferative syndrome. Clin Immunol 93:34\u201345","journal-title":"Clin Immunol"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.4049\/jimmunol.164.10.5319","volume":"164","author":"EL Masteller","year":"(2000)","unstructured":"Masteller EL, Chuang E, Mullen AC et al (2000) Structural analysis of CTLA-4 function in vivo. J Immunol 164:5319\u20135327","journal-title":"J Immunol"},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/00130832-200412000-00005","volume":"4","author":"T Oliveira JBFleisher","year":"(2004)","unstructured":"Oliveira JBFleisher T (2004) Autoimmune lymphoproliferative syndrome. Curr Opin Allergy Clin Immunol 4:497\u2013503","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1097\/00000478-199907000-00012","volume":"23","author":"P Strobel","year":"(1999)","unstructured":"Strobel P, Nanan R, Gattenlohner S et al (1999) Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95\/APO-1) deficiency. Am J Surg Pathol 23:829\u2013837","journal-title":"Am J Surg Pathol"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1182\/blood.V98.1.194","volume":"98","author":"SE Straus","year":"(2001)","unstructured":"Straus SE, Jaffe ES, Puck JM et al (2001) The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis. Blood 98:194\u2013200","journal-title":"Blood"},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1006\/smim.1997.0062","volume":"9","author":"P Depraetere VGolstein","year":"(1997)","unstructured":"Depraetere VGolstein P (1997) Fas and other cell death signaling pathways. Semin Immunol 9:93\u2013107","journal-title":"Semin Immunol"},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1084\/jem.183.3.721","volume":"183","author":"MJ Lenardo","year":"(1996)","unstructured":"Lenardo MJ (1996) Fas and the art of lymphocyte maintenance. J Exp Med 183:721\u2013724","journal-title":"J Exp Med"},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1002\/eji.1830241221","volume":"24","author":"I Behrmann","year":"(1994)","unstructured":"Behrmann I, Walczak HKrammer PH (1994) Structure of the human APO-1 gene. Eur J Immunol 24:3057\u20133062","journal-title":"Eur J Immunol"},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/0092-8674(95)90013-6","volume":"81","author":"GH Fisher","year":"(1995)","unstructured":"Fisher GH, Rosenberg FJ, Straus SE et al (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935\u2013946","journal-title":"Cell"},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1126\/science.7539157","volume":"268","author":"F Rieux-Laucat","year":"(1995)","unstructured":"Rieux-Laucat F, Le Deist F, Hivroz C et al (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347\u20131349","journal-title":"Science"},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1086\/302333","volume":"64","author":"CE Jackson","year":"(1999)","unstructured":"Jackson CE, Fischer RE, Hsu AP et al (1999) Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance. Am J Hum Genet 64:1002\u20131014","journal-title":"Am J Hum Genet"},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1172\/JCI115867","volume":"90","author":"MC Sneller","year":"(1992)","unstructured":"Sneller MC, Straus SE, Jaffe ES et al (1992) A novel lymphoproliferative\/autoimmune syndrome resembling murine lpr\/gld disease. J Clin Invest 90:334\u2013341","journal-title":"J Clin Invest"},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1006\/smim.1996.0056","volume":"9","author":"MC Puck JMSneller","year":"(1997)","unstructured":"Puck JMSneller MC (1997) ALPS: an autoimmune human lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis. Semin Immunol 9:77\u201384","journal-title":"Semin Immunol"},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1073\/pnas.0237359100","volume":"100","author":"AY Savinov","year":"(2003)","unstructured":"Savinov AY, Tcherepanov A, Green EA et al (2003) Contribution of Fas to diabetes development. Proc Natl Acad Sci U S A 100:628\u2013632","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1053\/gast.1997.v113.pm9322534","volume":"113","author":"L Pensati","year":"(1997)","unstructured":"Pensati L, Costanzo A, Ianni A et al (1997) Fas\/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology 113:1384\u20131389","journal-title":"Gastroenterology"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1126\/science.275.5302.960","volume":"275","author":"C Giordano","year":"(1997)","unstructured":"Giordano C, Stassi G, De Maria R et al (1997) Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto\u2019s thyroiditis. Science 275:960\u2013963","journal-title":"Science"},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/ni1054","volume":"5","author":"Y Ma","year":"(2004)","unstructured":"Ma Y, Liu H, Tu-Rapp H et al (2004) Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat Immunol 5:380\u2013387","journal-title":"Nat Immunol"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.4049\/jimmunol.162.3.1717","volume":"162","author":"S Jayaraman","year":"(1999)","unstructured":"Jayaraman S, Castro M, O\u2019Sullivan M et al (1999) Resistance to Fas-mediated T cell apoptosis in asthma. J Immunol 162:1717\u20131722","journal-title":"J Immunol"},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1097\/01.pas.0000157997.61177.08","volume":"29","author":"I Maric","year":"(2005)","unstructured":"Maric I, Pittaluga S, Dale JK et al (2005) Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome. Am J Surg Pathol 29:903\u2013911","journal-title":"Am J Surg Pathol"},{"key":"3_CR33","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1182\/blood-2004-09-3542","volume":"105","author":"DT Teachey","year":"(2005)","unstructured":"Teachey DT, Manno CS, Axsom KM et al. (2005) Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood 105:2443\u20132448","journal-title":"Blood"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1182\/blood.V90.11.4266","volume":"90","author":"TH Landowski","year":"(1997)","unstructured":"Landowski TH, Qu N, Buyuksal I et al (1997) Mutations in the Fas antigen in patients with multiple myeloma. Blood 90:4266\u20134270","journal-title":"Blood"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1182\/blood.V91.10.3943","volume":"91","author":"C Beltinger","year":"(1998)","unstructured":"Beltinger C, Kurz E, Bohler T et al (1998) CD95 (APO-1\/Fas) mutations in childhood T-lineage acute lymphoblastic leukemia. Blood 91:3943\u20133951","journal-title":"Blood"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1182\/blood.V92.9.3018","volume":"92","author":"K Gronbaek","year":"(1998)","unstructured":"Gronbaek K, Straten PT, Ralfkiaer E et al (1998) Somatic Fas mutations in non-Hodgkin\u2019s lymphoma: association with extranodal disease and autoimmunity. Blood 92:3018\u20133024","journal-title":"Blood"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0002-9440(10)65434-X","volume":"154","author":"MS Shin","year":"(1999)","unstructured":"Shin MS, Park WS, Kim SY et al (1999) Alterations of Fas (Apo-1\/CD95) gene in cutaneous malignant melanoma. Am J Pathol 154:1785\u20131791","journal-title":"Am J Pathol"},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1383-5742(01)00057-6","volume":"488","author":"L Mullauer","year":"(2001)","unstructured":"Mullauer L, Gruber P, Sebinger D et al (2001) Mutations in apoptosis genes: a pathogenetic factor for human disease. Mutat Res 488:211\u2013231","journal-title":"Mutat Res"},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.jneuroim.2003.10.002","volume":"146","author":"OH Kantarci","year":"(2004)","unstructured":"Kantarci OH, Hebrink DD, Achenbach SJ et al (2004) CD95 polymorphisms are associated with susceptibility to MS in women. A population-based study of CD95 and CD95L in MS. J Neuroimmunol 146:162\u2013170","journal-title":"J Neuroimmunol"},{"key":"3_CR40","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jneuroim.2004.12.001","volume":"161","author":"K Geleijns","year":"(2005)","unstructured":"Geleijns K, Laman JD, van Rijs W et al (2005) Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain\u2013Barre syndrome. J Neuroimmunol 161:183\u2013189","journal-title":"J Neuroimmunol"},{"key":"3_CR41","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.gene.6364259","volume":"6","author":"RL Nolsoe","year":"(2005)","unstructured":"Nolsoe RL, Kelly JA, Pociot F et al (2005) Functional promoter haplotypes of the human FAS gene are associated with the phenotype of SLE characterized by thrombocytopenia. Genes Immun 6:699\u2013706","journal-title":"Genes Immun"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000079253","volume":"52","author":"M Lucas","year":"(2004)","unstructured":"Lucas M, Zayas MD, De Costa AF et al (2004) A study of promoter and intronic markers of ApoI\/Fas gene and the interaction with Fas ligand in relapsing multiple sclerosis. Eur Neurol 52:12\u201317","journal-title":"Eur Neurol"},{"key":"3_CR43","first-page":"2397","volume":"27","author":"AI Bolstad","year":"(2000)","unstructured":"Bolstad AI, Wargelius A, Nakken B et al (2000) Fas and Fas ligand gene polymorphisms in primary Sjogren\u2019s syndrome. J Rheumatol 27:2397\u20132405","journal-title":"J Rheumatol"},{"key":"3_CR44","first-page":"1183","volume":"29","author":"S Kanemitsu","year":"(2002)","unstructured":"Kanemitsu S, Ihara K, Saifddin A et al (2002) A functional polymorphism in fas (CD95\/APO-1) gene promoter associated with systemic lupus erythematosus. J Rheumatol 29:1183\u20131188","journal-title":"J Rheumatol"},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1093\/rheumatology\/38.6.516","volume":"38","author":"T Horiuchi","year":"(1999)","unstructured":"Horiuchi T, Nishizaka H, Yasunaga S et al (1999) Association of Fas\/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese. Rheumatology (Oxford) 38:516\u2013520","journal-title":"Rheumatology (Oxford)"},{"key":"3_CR46","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ijc.10800","volume":"103","author":"HC Lai","year":"(2003)","unstructured":"Lai HC, Sytwu HK, Sun CA et al (2003) Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer 103:221\u2013225","journal-title":"Int J Cancer"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.4049\/jimmunol.165.3.1352","volume":"165","author":"BM Carreno","year":"(2000)","unstructured":"Carreno BM, Bennett F, Chau TA et al (2000) CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression. J Immunol 165:1352\u20131356","journal-title":"J Immunol"},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/35105024","volume":"1","author":"ML Alegre","year":"(2001)","unstructured":"Alegre ML, Frauwirth KAThompson CB (2001) T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol 1:220\u2013228","journal-title":"Nat Rev Immunol"},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nri727","volume":"2","author":"AH Sharpe","year":"(2002)","unstructured":"Sharpe AH, Freeman GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol 2:116\u2013126","journal-title":"Nat Rev Immunol"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/5.7.1075","volume":"5","author":"L Nistico","year":"(1996)","unstructured":"Nistico L, Buzzetti R, Pritchard LE et al (1996) The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 5:1075\u20131080","journal-title":"Belgian Diabetes Registry. Hum Mol Genet"},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"(2003)","unstructured":"Ueda H, Howson JM, Esposito L et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506\u2013511","journal-title":"Nature"},{"key":"3_CR52","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1399-0039.1998.tb02993.x","volume":"51","author":"J Braun","year":"(1998)","unstructured":"Braun J, Donner H, Siegmund T et al (1998) CTLA-4 promoter variants in patients with Graves\u2019 disease and Hashimoto\u2019s thyroiditis. Tissue Antigens 51:563\u2013566","journal-title":"Tissue Antigens"},{"key":"3_CR53","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1034\/j.1399-0039.1999.530112.x","volume":"53","author":"HF Harbo","year":"(1999)","unstructured":"Harbo HF, Celius EG, Vartdal F et al (1999) CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis. Tissue Antigens 53:106\u2013110","journal-title":"Tissue Antigens"},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ana.20577","volume":"58","author":"WY Chuang","year":"(2005)","unstructured":"Chuang WY, Strobel P, Gold R et al (2005) A CTLA4 high genotype is associated with myasthenia gravis in thymoma patients. Ann Neurol 58:644\u2013648","journal-title":"Ann Neurol"},{"key":"3_CR55","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ajh.20045","volume":"76","author":"M Monne","year":"(2004)","unstructured":"Monne M, Piras G, Palmas A et al (2004) Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin\u2019s lymphoma. Am J Hematol 76:14\u201318","journal-title":"Am J Hematol"},{"key":"3_CR56","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.cancergencyto.2005.07.020","volume":"165","author":"N Erfani","year":"(2006)","unstructured":"Erfani N, Razmkhah M, Talei AR et al (2006) Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer Genet Cytogenet 165:114\u2013120","journal-title":"Cancer Genet Cytogenet"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/sj.gene.6363752","volume":"2","author":"A Ligers","year":"(2001)","unstructured":"Ligers A, Teleshova N, Masterman T et al (2001) CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms. Genes Immun 2:145\u2013152","journal-title":"Genes Immun"},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s100380200086","volume":"47","author":"BS Shastry","year":"(2002)","unstructured":"Shastry BS (2002) SNP alleles in human disease and evolution. J Hum Genet 47:561\u2013566","journal-title":"J Hum Genet"},{"key":"3_CR59","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1002\/art.20347","volume":"50","author":"B Torres","year":"(2004)","unstructured":"Torres B, Aguilar F, Franco E et al (2004) Association of the CT60 marker of the CTLA4 gene with systemic lupus erythematosus. Arthritis Rheum 50:2211\u20132215","journal-title":"Arthritis Rheum"},{"key":"3_CR60","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s00439-002-0807-2","volume":"111","author":"LL Hudson","year":"(2002)","unstructured":"Hudson LL, Rocca K, Song YW et al (2002) CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region. Hum Genet 111:452\u2013455","journal-title":"Hum Genet"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S1525-1578(10)60576-4","volume":"7","author":"E Geissinger","year":"(2005)","unstructured":"Geissinger E, Bonzheim I, Krenacs L et al (2005) Identification of the tumor cells in peripheral T-cell lymphomas by combined polymerase chain reaction-based T-cell receptor beta spectrotyping and immunohistological detection with T-cell receptor beta chain variable region segment-specific antibodies. J Mol Diagn 7:455\u2013464","journal-title":"J Mol Diagn"},{"key":"3_CR62","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"(2005)","unstructured":"Barrett JC, Fry B, Maller J et al (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263\u2013265","journal-title":"Bioinformatics"},{"key":"3_CR63","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/ng1195-241","volume":"11","author":"L Lander EKruglyak","year":"(1995)","unstructured":"Lander EKruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241\u2013247","journal-title":"Nat Genet"},{"key":"3_CR64","doi-asserted-by":"publisher","first-page":"46478","DOI":"10.1074\/jbc.M206894200","volume":"277","author":"S Anjos","year":"(2002)","unstructured":"Anjos S, Nguyen A, Ounissi-Benkalha H et al (2002) A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 277:46478\u201346486","journal-title":"J Biol Chem"},{"key":"3_CR65","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","volume":"165","author":"T Kouki","year":"(2000)","unstructured":"Kouki T, Sawai Y, Gardine CA et al (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves\u2019 disease. J Immunol 165:6606\u20136611","journal-title":"J Immunol"},{"key":"3_CR66","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.0105-2896.2005.00249.x","volume":"204","author":"SC Gough","year":"(2005)","unstructured":"Gough SC, Walker LSSansom DM (2005) CTLA4 gene polymorphism and autoimmunity. Immunol Rev 204:102\u2013115","journal-title":"Immunol Rev"},{"key":"3_CR67","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.mcp.2005.05.004","volume":"20","author":"JE Niemela","year":"(2006)","unstructured":"Niemela JE, Hsu AP, Fleisher TA et al (2006) Single nucleotide polymorphisms in the apoptosis receptor gene TNFRSF6. Mol Cell Probes 20:21\u201326","journal-title":"Mol Cell Probes"},{"key":"3_CR68","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s001250051378","volume":"43","author":"RL Nolsoe","year":"(2000)","unstructured":"Nolsoe RL, Kristiansen OP, Sangthongpitag K et al (2000) Complete molecular scanning of the human Fas gene: mutational analysis and linkage studies in families with type I diabetes mellitus. The Danish Study Group of Diabetes in Childhood and The Danish IDDM Epidemiology and Genetics Group. Diabetologia 43:800\u2013808","journal-title":"Diabetologia"},{"key":"3_CR69","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1080\/1042819031000090228","volume":"44","author":"B Do","year":"(2003)","unstructured":"Do B, Lossos IS, Thorstenson Y et al. (2003) Analysis of FAS (CD95) gene mutations in higher-grade transformation of follicle center lymphoma. Leuk Lymphoma 44:1317\u20131323","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-008-0003-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12308-008-0003-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s12308-008-0003-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12308-008-0003-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T22:15:04Z","timestamp":1684361704000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12308-008-0003-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4,24]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s12308-008-0003-y","relation":{},"ISSN":["1865-5785"],"issn-type":[{"value":"1865-5785","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,24]]},"assertion":[{"value":"7 February 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}